Description
Product Overview
CJC-1295 No DAC + Ipamorelin is a combination research peptide containing a modified GHRH(1–29) analogue and a synthetic growth hormone secretagogue pentapeptide, supplied for laboratory research use only.
Published scientific literature has investigated the individual components in relation to GHRH receptor biology, GHSR-1a receptor biology, peptide stability and endocrine signaling research models.
Technical Specifications
- Product Name: CJC-1295 No DAC + Ipamorelin
- Product Type: Combination Research Peptide
- Amount: 10 mg total — 5 mg CJC-1295 No DAC + 5 mg Ipamorelin
- Form: Lyophilized Powder
- Purity: ≥99%
- Storage: 2–8°C
- Batch Testing: Batch-Specific COA Available
- Intended Use: Research Use Only
Batch Verification
Each batch is linked to a batch-specific Certificate of Analysis (COA).
Available documentation may include purity testing, identity verification, and batch-related analytical data.
Selected Scientific References
CJC-1295 No DAC / Modified GHRH(1–29)
Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM.
Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.
Journal of Clinical Investigation. 1986;78(4):906–913.
PMID: 3093533
DOI: 10.1172/JCI112679
Lance VA, Murphy WA, Sueiras-Diaz J, Coy DH.
Super-active analogs of growth hormone-releasing factor (1–29)-amide.
Biochemical and Biophysical Research Communications. 1984;119(1):265–272.
PMID: 6231028
DOI: 10.1016/0006-291X(84)91647-4
Ipamorelin
Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH.
Ipamorelin, the first selective growth hormone secretagogue.
European Journal of Endocrinology. 1998;139(5):552–561.
PMID: 9849822
DOI: 10.1530/eje.0.1390552
Gobburu JVS, Agersø H, Jusko WJ, Ynddal L.
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
Pharmaceutical Research. 1999;16(9):1412–1416.
PMID: 10496658
DOI: 10.1023/A:1018955126402
Research Profile
- Product Name: CJC-1295 No DAC + Ipamorelin
- Product Type: Combination Research Peptide
- Amount: 10 mg total — 5 mg CJC-1295 No DAC + 5 mg Ipamorelin
- Form: Lyophilized Powder
- Purity: ≥99%
- Storage: 2–8°C
- Batch Testing: Batch-Specific COA Available
- Intended Use: Research Use Only
Scope of Use
This product is supplied strictly for laboratory research purposes.
It is not intended for human use, veterinary use, diagnostic applications, or therapeutic and clinical applications.
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.





